Skip to main content
. 2022 Aug 25;10:990281. doi: 10.3389/fpubh.2022.990281

Table 1.

Patients' demographic and clinical characteristics.

All patients MDI group CSII group P-value
(n = 362) (n = 301) (n = 61)
Sex (M/F) 188/174 150/151 38/23 0.076
Age (years old) 26 (15,39) 29 (15,42) 25 (15,34) 0.192
Household incomea (¥/year) 100,000 (50,000–152,500) 100,000 (50,000–150,000) 100,000 (55,000–190,000) 0.820
Educational status (n%)
Less than bachelor's degree 85 (23.5) 73 (24.3) 12 (19.7) 0.072
Bachelor's degree or more 108 (29.8) 82 (27.2) 26 (42.6)
Unknown 169 (46.7) 146 (48.5) 23 (37.7)
Diabetes duration (years) 2.8 (0.8,7) 5 (0.8,6.7) 5.9 (1.1,11.1) 0.122
BMI (kg/m2) 20.4± 3.2 20.4 ± 3.3 20.1 ± 2.9 0.556
WHR 0.8 (0.8,0.9) 0.8 (0.8,0.9) 0.8 (0.8,0.9) 0.054
Insulin dose (U/kg/day) 0.6 (0.5,0.8) 0.7 (0.5,0.8) 0.6 (0.5,0.7) 0.167
SBP (mmHg) 113 (104,124) 115.4 (104,126) 109.3 (103,116) 0.009
DBP (mmHg) 71± 12 71 ± 12 69 ± 9 0.295
HbA1c (%) 8.0 (7.0,9.9) 8.7 (7.1,10) 8.1 (6.8,8.8) 0.007
HbA1c <7.5% (%) 36.2 32.9 52.5 0.004
FCP (pmol/L) 23.3 (16.5,92.2) 68.3 (16.5,96.8) 43 (16.5,60.8) 0.005
FBG (mmol/L) 8.8 (6.4,11.7) 9.6 (6.7,12.4) 7.5 (4.8,9.4) <0.001
TC (mmol/L) 4.2 (3.6,4.8) 4.3 (3.6,4.8) 4.4 (3.8,4.8) 0.791
TG (mmol/L) 0.7 (0.6,1.0) 0.9 (0.6,1.1) 1 (0.5,1) 0.637
HDL-c (mmol/L) 1.5 ± 0.4 1.5 ± 0.4 1.5 ± 0.3 0.736
LDL-c (mmol/L) 2.4 (1.9,2.9) 2.5 (1.9,3) 2.5 (2,2.9) 0.546

Data are shown as mean ± SD, median (IQR) and frequency.

BMI, body mass index; WHR, waist-to-hip ratio; MDI, multiple daily insulin injection; CSII, continuous subcutaneous insulin infusion; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; FCP, fasting C-peptide; FBG, fasting blood glucose; TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol.

P-values for CSII group vs. MDI group.

a

Missing data: 212 (70.4%) in MDI group; 36 (59%) in CSII group.